 Home > Active Ingredient News > Drugs Articles > KRAS inhibitors combined with SHP2 inhibitors for the treatment of lung cancer Mirati and Sanofi reach an agreement

KRAS inhibitors combined with SHP2 inhibitors for the treatment of lung cancer Mirati and Sanofi reach an agreement

 Last Update: 2021-10-22
 Source: Internet
 Author: User

Tags

hoskins cancer

sunblock cause cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On October 7, 2021, Mirati Therapeutics announced a clinical cooperation agreement with Sanofi

Adagrasib is a highly specific and potent oral KRAS G12C inhibitor, which has been optimized for long-lasting target inhibition

SAR442720 is a potent oral SHP inhibitor

▲SHP2 regulates the RAS signaling pathway (picture source: Revolution Medicines official website)

Because KRAS G12C inhibition and SHP2 inhibition have complementary mechanisms of action, they exhibit cumulative anti-tumor activity in preclinical models

Reference materials:

[1] Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer.

[1] Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer.
Retrieved October 8, 2021, from https://ir.
mirati.
com/press- releases/press-release-details/2021/Mirati-Therapeutics-to-Collaborate-with-Sanofi-on-Phase-12-Study-Evaluating-Combination-of-adagrasib-with-a-SHP2-Inhibitor-in-KRAS- G12C-mutated-Lung-Cancer/default.
aspx

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Tirzepatide Lyophilized powder Vial 5mg 10mg 15mg 20mg 30mg customize 99% Purity with third side checking report

CAS No.: 2023788-19-2

Pharmacy Grade

$50-60/UNIT FOB

Wight loss Lyophilized Semaglutide Petide powder CAS 910463-68-2 with 99.9% purity

CAS No.: 910463-68-2

Pharmacy Grade

$140-175/G FOB

High Quality (E,E,E,E)-Squalene CAS NO 111-02-4 GMP ISO9001 EP Pharma grade Manufacture

CAS No.: 111-02-4

EP Pharma grade

$400-405/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.